Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Neurological Biomarkers Market 2017 Forecast to 2022

March 2018 | 115 pages | ID: GB432DCFC36EN
GlobalInfoResearch

Abstracts

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus. In the era of molecular medicine, biomarkers usually mean molecular biomarkers and can be divided into 3 broad categories

Scope of the Report:

This report focuses on the Neurological Biomarkers in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• Thermo Fisher
• Merck
• Bio-Rad Laboratories
• Roche
• QIAGEN
• Athena Diagnostics
• Myriad RBM
• Cisbio Bioassays
• Wuxi APP
• BGI
• Aepodia
• Genewiz
• Proteome Sciences

Market Segment by Regions, regional analysis covers

• North America (USA, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Proteomics
• Genomics
• Imaging
• Bioinformatics
• Others

Market Segment by Applications, can be divided into

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

There are 15 Chapters to deeply display the global Neurological Biomarkers market.

Chapter 1, to describe Neurological Biomarkers Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Neurological Biomarkers, with sales, revenue, and price of Neurological Biomarkers, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Neurological Biomarkers, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Neurological Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Neurological Biomarkers sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
  1.2.1 Proteomics
  1.2.2 Genomics
  1.2.3 Imaging
  1.2.4 Bioinformatics
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Diagnostics
  1.3.2 Drug Discovery
  1.3.3 Personalized Medicine
  1.3.4 Others
1.4 Market Analysis by Regions
  1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Thermo Fisher
  2.1.1 Business Overview
    2.1.1.1 Thermo Fisher Neurological Biomarkers Description
    2.1.1.2 Thermo Fisher Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.1.2 Thermo Fisher Neurological Biomarkers Product Introduction
    2.1.2.1 Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
  2.1.3 Thermo Fisher Neurological Biomarkers Sales, Revenue and Market Share
    2.1.3.1 Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Thermo Fisher Neurological Biomarkers Market Share in Global in 2016
2.2 Merck
  2.2.1 Business Overview
    2.2.1.1 Merck Neurological Biomarkers Description
    2.2.1.2 Merck Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.2.2 Thermo Fisher Neurological Biomarkers Product Introduction
    2.2.2.1 Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Merck Neurological Biomarkers Product Introduction
  2.2.3 Merck Neurological Biomarkers Sales, Revenue and Market Share
    2.2.3.1 Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Merck Neurological Biomarkers Market Share in Global in 2016
2.3 Bio-Rad Laboratories
  2.3.1 Business Overview
    2.3.1.1 Bio-Rad Laboratories Neurological Biomarkers Description
    2.3.1.2 Bio-Rad Laboratories Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.3.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
    2.3.2.1 Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Bio-Rad Laboratories Neurological Biomarkers Product Introduction
  2.3.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Market Share
    2.3.3.1 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Bio-Rad Laboratories Neurological Biomarkers Market Share in Global in 2016
2.4 Roche
  2.4.1 Business Overview
    2.4.1.1 Roche Neurological Biomarkers Description
    2.4.1.2 Roche Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.4.2 Roche Neurological Biomarkers Product Introduction
    2.4.2.1 Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Roche Neurological Biomarkers Product Introduction
  2.4.3 Roche Neurological Biomarkers Sales, Revenue and Market Share
    2.4.3.1 Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Roche Neurological Biomarkers Market Share in Global in 2016
2.5 QIAGEN
  2.5.1 Business Overview
    2.5.1.1 QIAGEN Neurological Biomarkers Description
    2.5.1.2 QIAGEN Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.5.2 QIAGEN Neurological Biomarkers Product Introduction
    2.5.2.1 Production Bases, Sales Regions and Major Competitors
    2.5.2.2 QIAGEN Neurological Biomarkers Product Introduction
  2.5.3 QIAGEN Neurological Biomarkers Sales, Revenue and Market Share
    2.5.3.1 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 QIAGEN Neurological Biomarkers Market Share in Global in 2016
2.6 Athena Diagnostics
  2.6.1 Business Overview
    2.6.1.1 Athena Diagnostics Neurological Biomarkers Description
    2.6.1.2 Athena Diagnostics Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.6.2 Athena Diagnostics Neurological Biomarkers Product Introduction
    2.6.2.1 Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Athena Diagnostics Neurological Biomarkers Product Introduction
  2.6.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Market Share
    2.6.3.1 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Athena Diagnostics Neurological Biomarkers Market Share in Global in 2016
2.7 Myriad RBM
  2.7.1 Business Overview
    2.7.1.1 Myriad RBM Neurological Biomarkers Description
    2.7.1.2 Myriad RBM Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.7.2 Myriad RBM Neurological Biomarkers Product Introduction
    2.7.2.1 Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Myriad RBM Neurological Biomarkers Product Introduction
  2.7.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Market Share
    2.7.3.1 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Myriad RBM Neurological Biomarkers Market Share in Global in 2016
2.8 Cisbio Bioassays
  2.8.1 Business Overview
    2.8.1.1 Cisbio Bioassays Neurological Biomarkers Description
    2.8.1.2 Cisbio Bioassays Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.8.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
    2.8.2.1 Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Cisbio Bioassays Neurological Biomarkers Product Introduction
  2.8.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Market Share
    2.8.3.1 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Cisbio Bioassays Neurological Biomarkers Market Share in Global in 2016
2.9 Wuxi APP
  2.9.1 Business Overview
    2.9.1.1 Wuxi APP Neurological Biomarkers Description
    2.9.1.2 Wuxi APP Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.9.2 Wuxi APP Neurological Biomarkers Product Introduction
    2.9.2.1 Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Wuxi APP Neurological Biomarkers Product Introduction
  2.9.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Market Share
    2.9.3.1 Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Wuxi APP Neurological Biomarkers Market Share in Global in 2016
2.10 BGI
  2.10.1 Business Overview
    2.10.1.1 BGI Neurological Biomarkers Description
    2.10.1.2 BGI Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.10.2 BGI Neurological Biomarkers Product Introduction
    2.10.2.1 Production Bases, Sales Regions and Major Competitors
    2.10.2.2 BGI Neurological Biomarkers Product Introduction
  2.10.3 BGI Neurological Biomarkers Sales, Revenue and Market Share
    2.10.3.1 BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 BGI Neurological Biomarkers Market Share in Global in 2016
2.11 Aepodia
  2.11.1 Business Overview
    2.11.1.1 Aepodia Neurological Biomarkers Description
    2.11.1.2 Aepodia Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.11.2 Aepodia Neurological Biomarkers Product Introduction
    2.11.2.1 Production Bases, Sales Regions and Major Competitors
    2.11.2.2 Aepodia Neurological Biomarkers Product Introduction
  2.11.3 Aepodia Neurological Biomarkers Sales, Revenue and Market Share
    2.11.3.1 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11.3.2 Aepodia Neurological Biomarkers Market Share in Global in 2016
2.12 Genewiz
  2.12.1 Business Overview
    2.12.1.1 Genewiz Neurological Biomarkers Description
    2.12.1.2 Genewiz Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.12.2 Genewiz Neurological Biomarkers Product Introduction
    2.12.2.1 Production Bases, Sales Regions and Major Competitors
    2.12.2.2 Genewiz Neurological Biomarkers Product Introduction
  2.12.3 Genewiz Neurological Biomarkers Sales, Revenue and Market Share
    2.12.3.1 Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12.3.2 Genewiz Neurological Biomarkers Market Share in Global in 2016
2.13 Proteome Sciences
  2.13.1 Business Overview
    2.13.1.1 Proteome Sciences Neurological Biomarkers Description
    2.13.1.2 Proteome Sciences Neurological Biomarkers Headquarter, Main Business and Finance Overview
  2.13.2 Proteome Sciences Neurological Biomarkers Product Introduction
    2.13.2.1 Production Bases, Sales Regions and Major Competitors
    2.13.2.2 Proteome Sciences Neurological Biomarkers Product Introduction
  2.13.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Market Share
    2.13.3.1 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13.3.2 Proteome Sciences Neurological Biomarkers Market Share in Global in 2016

3 GLOBAL NEUROLOGICAL BIOMARKERS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Neurological Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neurological Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Neurological Biomarkers Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Neurological Biomarkers Manufacturer Market Share
  3.4.2 Top 5 Neurological Biomarkers Manufacturer Market Share
3.5 Market Competition Trend

4 GLOBAL NEUROLOGICAL BIOMARKERS MARKET ANALYSIS BY REGIONS

4.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Regions
  4.1.1 Global Neurological Biomarkers Sales by Regions (2012-2017)
  4.1.2 Global Neurological Biomarkers Revenue by Regions (2012-2017)
4.2 North America Neurological Biomarkers Sales and Growth (2012-2017)
4.3 Europe Neurological Biomarkers Sales and Growth (2012-2017)
4.4 Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2017)
4.5 South America Neurological Biomarkers Sales and Growth (2012-2017)
4.6 Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2017)

5 NORTH AMERICA NEUROLOGICAL BIOMARKERS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Neurological Biomarkers Sales, Revenue and Market Share by Countries
  5.1.1 North America Neurological Biomarkers Sales by Countries (2012-2017)
  5.1.2 North America Neurological Biomarkers Revenue by Countries (2012-2017)
  5.1.3 USA Neurological Biomarkers Sales and Growth (2012-2017)
  5.1.4 Canada Neurological Biomarkers Sales and Growth (2012-2017)
  5.1.5 Mexico Neurological Biomarkers Sales and Growth (2012-2017)
5.2 North America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 North America Neurological Biomarkers Sales by Manufacturers (2016-2017)
  5.2.2 North America Neurological Biomarkers Revenue by Manufacturers (2016-2017)
5.3 North America Neurological Biomarkers Sales by Type (2012-2017)
5.4 North America Neurological Biomarkers Sales by Application (2012-2017)

6 EUROPE NEUROLOGICAL BIOMARKERS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Neurological Biomarkers Sales, Revenue and Market Share by Countries
  6.1.1 Europe Neurological Biomarkers Sales by Countries (2012-2017)
  6.1.2 Europe Neurological Biomarkers Revenue by Countries (2012-2017)
  6.1.3 Germany Neurological Biomarkers Sales and Growth (2012-2017)
  6.1.4 UK Neurological Biomarkers Sales and Growth (2012-2017)
  6.1.5 France Neurological Biomarkers Sales and Growth (2012-2017)
  6.1.6 Russia Neurological Biomarkers Sales and Growth (2012-2017)
  6.1.7 Italy Neurological Biomarkers Sales and Growth (2012-2017)
6.2 Europe Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Europe Neurological Biomarkers Sales by Manufacturers (2016-2017)
  6.2.2 Europe Neurological Biomarkers Revenue by Manufacturers (2016-2017)
6.3 Europe Neurological Biomarkers Sales by Type (2012-2017)
6.4 Europe Neurological Biomarkers Sales by Application (2012-2017)

7 ASIA-PACIFIC NEUROLOGICAL BIOMARKERS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Neurological Biomarkers Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2017)
  7.1.2 Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2017)
  7.1.3 China Neurological Biomarkers Sales and Growth (2012-2017)
  7.1.4 Japan Neurological Biomarkers Sales and Growth (2012-2017)
  7.1.5 Korea Neurological Biomarkers Sales and Growth (2012-2017)
  7.1.6 India Neurological Biomarkers Sales and Growth (2012-2017)
  7.1.7 Southeast Asia Neurological Biomarkers Sales and Growth (2012-2017)
7.2 Asia-Pacific Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Neurological Biomarkers Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Neurological Biomarkers Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Neurological Biomarkers Sales by Type (2012-2017)
7.4 Asia-Pacific Neurological Biomarkers Sales by Application (2012-2017)

8 SOUTH AMERICA NEUROLOGICAL BIOMARKERS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Neurological Biomarkers Sales, Revenue and Market Share by Countries
  8.1.1 South America Neurological Biomarkers Sales by Countries (2012-2017)
  8.1.2 South America Neurological Biomarkers Revenue by Countries (2012-2017)
  8.1.3 Brazil Neurological Biomarkers Sales and Growth (2012-2017)
  8.1.4 Argentina Neurological Biomarkers Sales and Growth (2012-2017)
  8.1.5 Columbia Neurological Biomarkers Sales and Growth (2012-2017)
8.2 South America Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
  8.2.1 South America Neurological Biomarkers Sales by Manufacturers (2016-2017)
  8.2.2 South America Neurological Biomarkers Revenue by Manufacturers (2016-2017)
8.3 South America Neurological Biomarkers Sales by Type (2012-2017)
8.4 South America Neurological Biomarkers Sales by Application (2012-2017)

9 MIDDLE EAST AND AFRICA NEUROLOGICAL BIOMARKERS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Neurological Biomarkers Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2017)
  9.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2017)
  9.1.3 Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017)
  9.1.4 UAE Neurological Biomarkers Sales and Growth (2012-2017)
  9.1.5 Egypt Neurological Biomarkers Sales and Growth (2012-2017)
  9.1.6 Nigeria Neurological Biomarkers Sales and Growth (2012-2017)
  9.1.7 South Africa Neurological Biomarkers Sales and Growth (2012-2017)
9.2 Middle East and Africa Neurological Biomarkers Sales and Revenue (value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Neurological Biomarkers Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Neurological Biomarkers Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Neurological Biomarkers Sales by Type (2012-2017)
9.4 Middle East and Africa Neurological Biomarkers Sales by Application (2012-2017)

10 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY TYPE

10.1 Global Neurological Biomarkers Sales, Revenue and Market Share by Type (2012-2017)
  10.1.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2017)
  10.1.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
10.2 Proteomics Sales Growth and Price
  10.2.1 Global Proteomics Sales Growth (2012-2017)
  10.2.2 Global Proteomics Price (2012-2017)
10.3 Genomics Sales Growth and Price
  10.3.1 Global Genomics Sales Growth (2012-2017)
  10.3.2 Global Genomics Price (2012-2017)
10.4 Imaging Sales Growth and Price
  10.4.1 Global Imaging Sales Growth (2012-2017)
  10.4.2 Global Imaging Price (2012-2017)
10.5 Bioinformatics Sales Growth and Price
  10.5.1 Global Bioinformatics Sales Growth (2012-2017)
  10.5.2 Global Bioinformatics Price (2012-2017)
10.6 Others Sales Growth and Price
  10.6.1 Global Others Sales Growth (2012-2017)
  10.6.2 Global Others Price (2012-2017)

11 GLOBAL NEUROLOGICAL BIOMARKERS MARKET SEGMENT BY APPLICATION

11.1 Global Neurological Biomarkers Sales Market Share by Application (2012-2017)
11.2 Diagnostics Sales Growth (2012-2017)
11.3 Drug Discovery Sales Growth (2012-2017)
11.4 Personalized Medicine Sales Growth (2012-2017)
11.5 Others Sales Growth (2012-2017)

12 NEUROLOGICAL BIOMARKERS MARKET FORECAST (2017-2022)

12.1 Global Neurological Biomarkers Sales, Revenue and Growth Rate (2017-2022)
12.2 Neurological Biomarkers Market Forecast by Regions (2017-2022)
  12.2.1 North America Neurological Biomarkers Market Forecast (2017-2022)
  12.2.2 Europe Neurological Biomarkers Market Forecast (2017-2022)
  12.2.3 Asia-Pacific Neurological Biomarkers Market Forecast (2017-2022)
  12.2.4 South America Neurological Biomarkers Market Forecast (2017-2022)
  12.2.5 Middle East and Africa Neurological Biomarkers Market Forecast (2017-2022)
12.3 Neurological Biomarkers Market Forecast by Type (2017-2022)
12.4 Neurological Biomarkers Market Forecast by Application (2017-2022)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Neurological Biomarkers Picture
Table Product Specifications of Neurological Biomarkers
Figure Global Sales Market Share of Neurological Biomarkers by Types in 2016
Table Neurological Biomarkers Types for Major Manufacturers
Figure Proteomics Picture
Figure Genomics Picture
Figure Imaging Picture
Figure Bioinformatics Picture
Figure Others Picture
Table Neurological Biomarkers Sales Market Share by Applications in 2016
Figure Diagnostics Picture
Figure Drug Discovery Picture
Figure Personalized Medicine Picture
Figure Others Picture
Figure USA Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure France Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure UK Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure China Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure India Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Neurological Biomarkers Revenue (Value) and Growth Rate (2012-2022)
Table Thermo Fisher Headquarter, Established, Main Business and Finance Overview (2016)
Table Thermo Fisher Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Thermo Fisher Neurological Biomarkers Product
Table Thermo Fisher Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Neurological Biomarkers Sales Market Share in Global in 2016
Table Thermo Fisher Neurological Biomarkers Revenue Market Share in Global in 2016
Table Merck Headquarter, Established, Main Business and Finance Overview (2016)
Table Merck Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Merck Neurological Biomarkers Product
Table Merck Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Neurological Biomarkers Sales Market Share in Global in 2016
Table Merck Neurological Biomarkers Revenue Market Share in Global in 2016
Table Bio-Rad Laboratories Headquarter, Established, Main Business and Finance Overview (2016)
Table Bio-Rad Laboratories Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Bio-Rad Laboratories Neurological Biomarkers Product
Table Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Rad Laboratories Neurological Biomarkers Sales Market Share in Global in 2016
Table Bio-Rad Laboratories Neurological Biomarkers Revenue Market Share in Global in 2016
Table Roche Headquarter, Established, Main Business and Finance Overview (2016)
Table Roche Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Roche Neurological Biomarkers Product
Table Roche Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Neurological Biomarkers Sales Market Share in Global in 2016
Table Roche Neurological Biomarkers Revenue Market Share in Global in 2016
Table QIAGEN Headquarter, Established, Main Business and Finance Overview (2016)
Table QIAGEN Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table QIAGEN Neurological Biomarkers Product
Table QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table QIAGEN Neurological Biomarkers Sales Market Share in Global in 2016
Table QIAGEN Neurological Biomarkers Revenue Market Share in Global in 2016
Table Athena Diagnostics Headquarter, Established, Main Business and Finance Overview (2016)
Table Athena Diagnostics Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Athena Diagnostics Neurological Biomarkers Product
Table Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Athena Diagnostics Neurological Biomarkers Sales Market Share in Global in 2016
Table Athena Diagnostics Neurological Biomarkers Revenue Market Share in Global in 2016
Table Myriad RBM Headquarter, Established, Main Business and Finance Overview (2016)
Table Myriad RBM Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Myriad RBM Neurological Biomarkers Product
Table Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad RBM Neurological Biomarkers Sales Market Share in Global in 2016
Table Myriad RBM Neurological Biomarkers Revenue Market Share in Global in 2016
Table Cisbio Bioassays Headquarter, Established, Main Business and Finance Overview (2016)
Table Cisbio Bioassays Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Cisbio Bioassays Neurological Biomarkers Product
Table Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cisbio Bioassays Neurological Biomarkers Sales Market Share in Global in 2016
Table Cisbio Bioassays Neurological Biomarkers Revenue Market Share in Global in 2016
Table Wuxi APP Headquarter, Established, Main Business and Finance Overview (2016)
Table Wuxi APP Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Wuxi APP Neurological Biomarkers Product
Table Wuxi APP Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wuxi APP Neurological Biomarkers Sales Market Share in Global in 2016
Table Wuxi APP Neurological Biomarkers Revenue Market Share in Global in 2016
Table BGI Headquarter, Established, Main Business and Finance Overview (2016)
Table BGI Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table BGI Neurological Biomarkers Product
Table BGI Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Neurological Biomarkers Sales Market Share in Global in 2016
Table BGI Neurological Biomarkers Revenue Market Share in Global in 2016
Table Aepodia Headquarter, Established, Main Business and Finance Overview (2016)
Table Aepodia Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Aepodia Neurological Biomarkers Product
Table Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aepodia Neurological Biomarkers Sales Market Share in Global in 2016
Table Aepodia Neurological Biomarkers Revenue Market Share in Global in 2016
Table Genewiz Headquarter, Established, Main Business and Finance Overview (2016)
Table Genewiz Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Genewiz Neurological Biomarkers Product
Table Genewiz Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genewiz Neurological Biomarkers Sales Market Share in Global in 2016
Table Genewiz Neurological Biomarkers Revenue Market Share in Global in 2016
Table Proteome Sciences Headquarter, Established, Main Business and Finance Overview (2016)
Table Proteome Sciences Neurological Biomarkers Production Bases, Sales Regions and Major Competitors
Table Proteome Sciences Neurological Biomarkers Product
Table Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Proteome Sciences Neurological Biomarkers Sales Market Share in Global in 2016
Table Proteome Sciences Neurological Biomarkers Revenue Market Share in Global in 2016
Table Global Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Global Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Global Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Global Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Global Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Global Neurological Biomarkers Price by Manufacturer (2016-2017)
Figure Global Neurological Biomarkers Sales and Growth (2012-2017)
Figure Global Neurological Biomarkers Revenue and Growth (2012-2017)
Table Global Neurological Biomarkers Sales by Regions (2012-2017)
Table Global Neurological Biomarkers Sales Market Share by Regions (2012-2017)
Table Global Neurological Biomarkers Revenue by Regions (2012-2017)
Figure Global Neurological Biomarkers Revenue Market Share by Regions in 2012
Figure Global Neurological Biomarkers Revenue Market Share by Regions in 2016
Figure North America Neurological Biomarkers Sales and Growth (2012-2017)
Figure Europe Neurological Biomarkers Sales and Growth (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Sales and Growth (2012-2017)
Figure South America Neurological Biomarkers Sales and Growth (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Sales and Growth (2012-2017)
Figure North America Neurological Biomarkers Revenue and Growth (2012-2017)
Table North America Neurological Biomarkers Sales by Countries (2012-2017)
Table North America Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure North America Neurological Biomarkers Sales Market Share by Countries in 2012
Figure North America Neurological Biomarkers Sales Market Share by Countries in 2016
Table North America Neurological Biomarkers Revenue by Countries (2012-2017)
Table North America Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2012
Figure North America Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure USA Neurological Biomarkers Sales and Growth (2012-2017)
Figure Canada Neurological Biomarkers Sales and Growth (2012-2017)
Figure Mexico Neurological Biomarkers Sales and Growth (2012-2017)
Table North America Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure North America Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure North America Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table North America Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure North America Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure North America Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table North America Neurological Biomarkers Sales by Type (2012-2017)
Table North America Neurological Biomarkers Sales Share by Type (2012-2017)
Table North America Neurological Biomarkers Sales by Application (2012-2017)
Table North America Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Europe Neurological Biomarkers Revenue and Growth (2012-2017)
Table Europe Neurological Biomarkers Sales by Countries (2012-2017)
Table Europe Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Europe Neurological Biomarkers Revenue by Countries (2012-2017)
Table Europe Neurological Biomarkers Revenue Market Share by Countries in 2012
Table Europe Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Germany Neurological Biomarkers Sales and Growth (2012-2017)
Figure UK Neurological Biomarkers Sales and Growth (2012-2017)
Figure France Neurological Biomarkers Sales and Growth (2012-2017)
Figure Russia Neurological Biomarkers Sales and Growth (2012-2017)
Figure Italy Neurological Biomarkers Sales and Growth (2012-2017)
Table Europe Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Europe Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Europe Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Europe Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Europe Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Europe Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Europe Neurological Biomarkers Sales by Type (2012-2017)
Table Europe Neurological Biomarkers Sales Share by Type (2012-2017)
Table Europe Neurological Biomarkers Sales by Application (2012-2017)
Table Europe Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Asia-Pacific Neurological Biomarkers Revenue and Growth (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue by Countries (2012-2017)
Table Asia-Pacific Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure China Neurological Biomarkers Sales and Growth (2012-2017)
Figure Japan Neurological Biomarkers Sales and Growth (2012-2017)
Figure Korea Neurological Biomarkers Sales and Growth (2012-2017)
Figure India Neurological Biomarkers Sales and Growth (2012-2017)
Figure Southeast Asia Neurological Biomarkers Sales and Growth (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Neurological Biomarkers Sales by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share by Type (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales by Application (2012-2017)
Table Asia-Pacific Neurological Biomarkers Sales Share by Application (2012-2017)
Figure South America Neurological Biomarkers Revenue and Growth (2012-2017)
Table South America Neurological Biomarkers Sales by Countries (2012-2017)
Table South America Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure South America Neurological Biomarkers Sales Market Share by Countries in 2016
Table South America Neurological Biomarkers Revenue by Countries (2012-2017)
Table South America Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure South America Neurological Biomarkers Revenue Market Share by Countries in 2017
Figure Brazil Neurological Biomarkers Sales and Growth (2012-2017)
Figure Argentina Neurological Biomarkers Sales and Growth (2012-2017)
Figure Columbia Neurological Biomarkers Sales and Growth (2012-2017)
Table South America Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure South America Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure South America Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table South America Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure South America Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure South America Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table South America Neurological Biomarkers Sales by Type (2012-2017)
Table South America Neurological Biomarkers Sales Share by Type (2012-2017)
Table South America Neurological Biomarkers Sales by Application (2012-2017)
Table South America Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Revenue and Growth (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales by Countries (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Countries in 2016
Table Middle East and Africa Neurological Biomarkers Revenue by Countries (2012-2017)
Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2012
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neurological Biomarkers Sales and Growth (2012-2017)
Figure UAE Neurological Biomarkers Sales and Growth (2012-2017)
Figure Egypt Neurological Biomarkers Sales and Growth (2012-2017)
Figure Nigeria Neurological Biomarkers Sales and Growth (2012-2017)
Figure South Africa Neurological Biomarkers Sales and Growth (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Neurological Biomarkers Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Neurological Biomarkers Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Neurological Biomarkers Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Neurological Biomarkers Sales by Type (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales Share by Type (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales by Application (2012-2017)
Table Middle East and Africa Neurological Biomarkers Sales Share by Application (2012-2017)
Table Global Neurological Biomarkers Sales by Type (2012-2017)
Table Global Neurological Biomarkers Sales Share by Type (2012-2017)
Table Global Neurological Biomarkers Revenue by Type (2012-2017)
Table Global Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Global Proteomics Sales Growth (2012-2017)
Figure Global Proteomics Price (2012-2017)
Figure Global Genomics Sales Growth (2012-2017)
Figure Global Genomics Price (2012-2017)
Figure Global Imaging Sales Growth (2012-2017)
Figure Global Imaging Price (2012-2017)
Figure Global Bioinformatics Sales Growth (2012-2017)
Figure Global Bioinformatics Price (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Others Price (2012-2017)
Table Global Neurological Biomarkers Sales by Application (2012-2017)
Table Global Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Global Diagnostics Sales Growth (2012-2017)
Figure Global Drug Discovery Sales Growth (2012-2017)
Figure Global Personalized Medicine Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Neurological Biomarkers Sales, Revenue and Growth Rate (2017 -2022)
Table Global Neurological Biomarkers Sales Forecast by Regions (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Regions (2017-2022)
Figure North America Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Europe Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Asia-Pacific Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure South America Sales Neurological Biomarkers Market Forecast (2017-2022)
Figure Middle East and Africa Sales Neurological Biomarkers Market Forecast (2017-2022)
Table Global Neurological Biomarkers Sales Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Type (2017-2022)
Table Global Neurological Biomarkers Sales Forecast by Application (2017-2022)
Table Global Neurological Biomarkers Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List